Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference product sponsors as well as...more
Amgen, Sandoz, Samsung and Mylan all launched adalimumab biosimilars in Europe this past October. On October 16, 2018, Amgen has announced that its adalimumab biosimilar AMGEVITA launched in European markets....more
Here are our picks for the top-5 biggest deals in the world of biosimilars in 2017...more
Here are our picks for the top-five most significant U.S. market developments in the world of biosimilars in 2017...more